Norway'S Pharmaceutical Revolution: Pursuing And Accomplishing Innovation In Nyegaard & Co., 1945-1997

The pharmaceutical revolution that gathered pace in the 1930s delivered a plethora of almost magical new drugs such as penicillin, streptomycin, cortisone, and the birth control pill. This revolution grew from academic-business relationships in five countries: USA, Germany, Great Britain,Switzerland, and France. Many other countries tried and failed to replicate this success, yet a handful of Scandinavia companies made important breakthroughs in a narrow band of specialities. This is the story of how one Norwegian company-- Nyegaard and Co. --achieved international success from the1970s onwards with a breakthrough product facilitating X-ray pictures of the soft tissues of the body. The company succeeded by harnessing research skills and creating scientific and business alliances abroad, building its own momentum step by step: the corporation as entrepreneur. It thereby brokewith the conventional way a national medical ecosystem facilitated the crucial scientific progress. This is a story both of personal initiatives and great organizational transformations in several stages. In the 1950s, Nyegaard and Co. was a small hierarchical home market-oriented generics company.By the end of the 1990s, it had developed into a fairly large and multinational hierarchical company, preoccupied as much with shareholder value as scientific progress. It has also become a company that no longer had the same ability to innovate as before and therefore became merged into anotherone.

• | Author: Knut Sogner
• | Publisher: Oxford University Press
• | Publication Date: Dec 15, 2022
• | Number of Pages: 272 pages
• | Language: English
• | Binding: Hardcover
• | ISBN-10: 0192869000
• | ISBN-13: 9780192869005